Abstract Background and Aims The Coronavirus disease 2019 (COVID‐19) pandemic
globally changed the priorities of medical and surgical procedures. It has caused many …

Sickle cell disease is the most common hemoglobinopathy among humans. As the condition
promotes susceptibility to infections, chronic inflammation, and hypercoagulability disorders …

An understanding of the behavior of SARS-CoV-2 in pediatric hematology-oncology patients
is essential to the optimal management of these patients during the COVID-19 pandemic …

During the coronavirus-19 disease (COVID-19) pandemic, several studies were performed
to determine the mortality and incidence rates of coronavirus infection among patients with …

COVID-19 is a systemic infection that leads to multisystem affection, including hematological
changes. On the other hand, the patients who have certain hematological diseases are more …

Letter to the editor, In 2020, the SARS-CoV-2 virus spread all over the world also affecting
patients with hematologic diseases. 1 Patients with aplastic anemia (AA) were thought to be …

COVID-19 is the respiratory illness caused by the beta coronavirus SARS-CoV-2. COVID-19
is complicated by an increased risk for adverse thrombotic events that promote organ failure …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been widely documented as a multi-systemic …

Abstract Hemoglobin D-Los Angeles is a variant of hemoglobin that can polymerize in the
deoxygenated state. When co-inherited with Hemoglobin S (HbSD-Los Angeles disease) a …

The course of infection with SARS-CoV-2 virus in patients with congenital bleeding
disorders does not differ from the general population. COVID-19 in these patients can be …